Format

Send to

Choose Destination
Lancet Oncol. 2019 May 10. pii: S1470-2045(19)30289-X. doi: 10.1016/S1470-2045(19)30289-X. [Epub ahead of print]

New treatment for relapsed or refractory Hodgkin's lymphoma.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center